Anika Therapeutics Appoints Cheryl Blanchard Interim CEO

Anika Therapeutics (NASDAQ: [[ticker:ANIK]]) board member Cheryl Blanchard has been named interim CEO of the company. Her appointment comes two weeks after the death of CEO Joseph Darling. With Blanchard stepping into her new role, the interim “Office of the President” that was created to take on Darling’s duties has been dissolved.

Blanchard has been an Anika board member since 2018. Her experience includes serving as chief executive of Microchips Biotech, as well as senior roles at Zimmer. Bedford, MA-based Anika develops and sells joint preservation and regenerative therapies for orthopedic conditions.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.